Isoflavones Market Future Prospects And Opportunities 2023-2032

1
Isoflavones Market Size to Cross USD 28 Bn by
2032
2
Overview of Isoflavones Market

• Isoflavones Market is anticipated to witness
  considerable gains by 2032 on account of
  expanding nutraceutical industry in Asia Pacific.
  Growing consumer awareness about healthy diets
  influenced by the pandemic has proliferated the
  demand for dietary supplements in the region,
  paving the way for industry growth. As per the
  Ministry of Food Processing Industries data,
  India's nutraceutical market is poised to reach
  USD 18 billion by 2025.
• Isoflavones supplements have gained huge
  popularity in alleviating menopausal symptoms and
  offer protection against age-related diseases
  such as osteoporosis, cardiovascular disorders,
  and others. As per CDC, stroke affects over
  795,000 people annually in the U.S. alone.
  Therefore, the rising prevalence of these
  disorders will propel the demand for
  nutraceuticals in the region, thus, transforming
  market dynamics.

3
Continue

• Based on source, isoflavones industry from red
  clover segment is slated to record a valuation of
  more than USD 1.5 billion by 2032, owing to
  rising health consciousness among consumers.
  Healthy eating patterns have bolstered the demand
  for plant protein ingredients such as red clover.
  Moreover, red clover helps manage various
  conditions, such as whooping cough, gout, asthma,
  and cancer, while relieving osteoporosis and
  menopause symptoms.
• With respect to application, isoflavones market
  from cosmetics segment is expected to garner
  significant gains through 2032. Isoflavones have
  gained immense traction as a skincare ingredient
  across the cosmetic sector, owing to their
  anti-aging and antioxidant properties.
  Additionally, they help maintain the pH balance,
  which makes them suitable for luxury and
  prescription cosmetics. Expanding cosmetics
  industry in developing European economies, such
  as France, Poland, Italy, and Germany, is likely
  to bolster segment gains during 2023-2032.

4
Continue

• In terms of the regional landscape, Asia Pacific
  isoflavones industry is poised to grow at over
  5.5 CAGR from 2023 to 2032 on account of surging
  occurrence of diabetes and cardiovascular
  disorders. As per WHO, nearly 77 million people
  in India 18 years and above are type 2 diabetic,
  and about 25 million are prediabetic. Growing
  prevalence of these disorders has increased
  consumer preferences toward nutraceuticals, which
  is likely to bolster the demand for isoflavones
  in the region.
• Notable participants in the Isoflavones market
  include ADM, Medisys Biotech, Guzen Development,
  Fujicco Co., Ltd, HerboNutra, Frutarom Ltd., SK
  Bioland, Aushadhi Herbal, Nutra Green
  Biotechnology Co., Ltd., and Tradichem

5
Browse Full Research Report On Isoflavones Market
_at_ https//bit.ly/3LcGI7d Request for a sample
of this research report _at_ https//bit.ly/3oPIZxJ

6
Stay In Touch Website www.gminsights.com Social
Media